Company Profile
Bio Solution develops, manufactures, and sells cell therapy products globally. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects.
Its portfolio also includes KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds, and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds Reconstructed human micro-tissue models comprising KeraSkin, an epidermis model.
Its portfolio also includes KeraSkin-FT, a full-thickness skin model, KeraSkin-M, a pigmented skin model, corneal models, SoluAirway, a airway mucosa model, SoluOral, an oral mucosa model, SoluDPNeuron, a dopaminergic neuron model, SoluDANeuron, an islet model, and SoluLiver, a liver model.
Additionally, it provides human-derived primary cell cultures and primary cells for in vitro research. Its portfolio also includes bio advanced materials, and cosmetics raw materials. in January 2016.
Bio Solution Co.,Ltd. The company was formerly known as MCTT Bio Co., Ltd. and changed its name to Bio Solution Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.